Articles Tagged: Orange Book
On March 30th,
the Federal Trade Commission filed a lawsuit against drug manufacturer Endo
Pharmaceuticals, alleging that Endo is paying generic drug manufacturers in order to
delay the release of lower cost generic versions of their drugs, Opana ER and
Lidoderm.
Generic drugs
come to market when the patents on name brand drugs expire.
Continue Reading
Posted in:
Docket Alarm is
excited to announce the release of a new report: “Big Pharma and the Legal Industry: Docket
Alarm’s Guide to Orange Book Patent Analytics”.
The report,
presented in a visually engaging infographic, breaks down how the relatively
new Patent Trial and Appeal Board is reshaping Hatch-Waxman litigation.
Attorneys can see statistics on everything from the trajectory of Orange Book
patents at the PTAB to the top players in the field.
Get your free
copy of “Big Pharma and the Legal Industry: Docket
Alarm’s Guide to Orange Book Patent Analytics”.
* * *
Docket Alarm is the only research
platform that offers patent practitioners a complete PTAB research and
analytics platform featuring Orange Book patents engaged in litigation.
Continue Reading
Posted in:
RFC Express was, until recently, a well-known IP litigation alert provider that offered easy access to case alerts at a reasonable rate. Unfortunately, the service has appeared to have shuttered its doors. Many users stopped receiving case alerts without warning.
Fortunately, former RFC Express users are not left without options. Docket Alarm can meet all of their research needs and much more.
Blazing Fast Alerts Over a Comprehensive Database
Like RFC Express, Docket Alarm offers users access to IP cases from U.S. Federal District Courts.
Continue Reading
Posted in:
Docket Alarm is pleased
to announce the first legal research platform to provide Orange Book litigators a suite of tools
for their practice. The
features include the ability to track changes to the Orange Book and related
litigation, search correspondence between drug companies and the FDA, and
analytics on Orange Book cases in the Patent Trial and Appeal Board (PTAB).
What is the Orange Book?
The
“Orange Book,” published since 1980, is the authoritative resource on FDA
approved drugs for patent litigators.
Continue Reading
Posted in:
Stay Connected